Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Nanobiotechnology
|
June 16, 2025
An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy through Zn<sup>2+</sup> overload triggered pyroptosis
Liming Gong, Yanhong Liu, Jing Feng, et al.
Pharmaceutics
|
May 28, 2022
Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment
Yingying Zhang, Hongxia Duan, Heming Zhao, et al.
Pharmaceutics
|
November 27, 2021
Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π-π Stacking and Its Therapeutic Application in Bladder Cancer
Lingling Qi, Chao Liu, Yingying Zhang, et al.
Pharmaceutics
|
June 9, 2025
Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π-π Stacking and Its Therapeutic Application in Bladder Cancer. <i>Pharmaceutics</i> 2021, <i>13</i>, 1776
Lingling Qi, Chao Liu, Yingying Zhang, et al.
Pharmaceutics
|
July 29, 2023
Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
Heming Zhao, Liming Gong, Hao Wu, et al.
Pharmaceutics
|
February 26, 2025
Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer
Liming Gong, Heming Zhao, Liqing Chen, et al.
European Urology Open Science
|
November 8, 2024
Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma
Honglei Cui, Jie Wu, Gan Du, et al.
BMC Medical Genomics
|
May 5, 2022
Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
Youyan Guan, Xiaobing Wang, Kaopeng Guan, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
April 29, 2025
Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC
Qi Zhang, Yanhua Du, Dong Wang, et al.
Cancer Research and Treatment
|
February 16, 2021
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
Hongzhe Shi, Wen Zhang, Xingang Bi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Nanobiotechnology
|
June 16, 2025
An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy through Zn<sup>2+</sup> overload triggered pyroptosis
Liming Gong, Yanhong Liu, Jing Feng, et al.
Pharmaceutics
|
May 28, 2022
Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment
Yingying Zhang, Hongxia Duan, Heming Zhao, et al.
Pharmaceutics
|
November 27, 2021
Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π-π Stacking and Its Therapeutic Application in Bladder Cancer
Lingling Qi, Chao Liu, Yingying Zhang, et al.
Pharmaceutics
|
June 9, 2025
Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π-π Stacking and Its Therapeutic Application in Bladder Cancer. <i>Pharmaceutics</i> 2021, <i>13</i>, 1776
Lingling Qi, Chao Liu, Yingying Zhang, et al.
Pharmaceutics
|
July 29, 2023
Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
Heming Zhao, Liming Gong, Hao Wu, et al.
Pharmaceutics
|
February 26, 2025
Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer
Liming Gong, Heming Zhao, Liqing Chen, et al.
European Urology Open Science
|
November 8, 2024
Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma
Honglei Cui, Jie Wu, Gan Du, et al.
BMC Medical Genomics
|
May 5, 2022
Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
Youyan Guan, Xiaobing Wang, Kaopeng Guan, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
April 29, 2025
Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC
Qi Zhang, Yanhua Du, Dong Wang, et al.
Cancer Research and Treatment
|
February 16, 2021
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
Hongzhe Shi, Wen Zhang, Xingang Bi, et al.
Page
of 2